PH12016501647B1 - Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency - Google Patents

Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency

Info

Publication number
PH12016501647B1
PH12016501647B1 PH12016501647A PH12016501647A PH12016501647B1 PH 12016501647 B1 PH12016501647 B1 PH 12016501647B1 PH 12016501647 A PH12016501647 A PH 12016501647A PH 12016501647 A PH12016501647 A PH 12016501647A PH 12016501647 B1 PH12016501647 B1 PH 12016501647B1
Authority
PH
Philippines
Prior art keywords
vitamin
oral liquid
estabilized
containing zinc
supplements containing
Prior art date
Application number
PH12016501647A
Other versions
PH12016501647A1 (en
Inventor
Joyce Bedelia B Santos
Kennie U Dee
Original Assignee
Novex Science Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novex Science Pte Ltd filed Critical Novex Science Pte Ltd
Publication of PH12016501647B1 publication Critical patent/PH12016501647B1/en
Publication of PH12016501647A1 publication Critical patent/PH12016501647A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

An aqueous oral liquid composition containing vitamin C, zinc, a stabilizing amount of carbomer to reduce the zinc-catalyzed degradation of vitamin C, and a combination of chloride ion and high intensity sweetener to reduce the astringency of the formulation.
PH12016501647A 2014-02-18 2016-08-17 Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency PH12016501647A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2014/000007 WO2015126265A1 (en) 2014-02-18 2014-02-18 Oral liquid vitamin supplements containing zinc and stabilized vitamin c with reduced astringency

Publications (2)

Publication Number Publication Date
PH12016501647B1 true PH12016501647B1 (en) 2017-02-06
PH12016501647A1 PH12016501647A1 (en) 2017-02-06

Family

ID=53878646

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016501647A PH12016501647A1 (en) 2014-02-18 2016-08-17 Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency

Country Status (2)

Country Link
PH (1) PH12016501647A1 (en)
WO (1) WO2015126265A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112315827B (en) * 2020-09-25 2023-02-28 好维股份有限公司 Oral care composition and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000944A (en) * 1989-06-09 1991-03-19 Colgate-Palmolive Company Zinc-containing oral products with reduced astringency
HU207799B (en) * 1991-07-24 1993-06-28 Beres Export Import Rt Process for producing pharmaceutical composition for influencing the reticuloendothelial system, for treating chronic pain symptomes of degenerative locomotor disorders or tumors, and for treating mucoviscidosis
GB0007760D0 (en) * 2000-03-30 2000-05-17 Smithkline Beckman Corp Composition
JP3590051B1 (en) * 2003-07-30 2004-11-17 花王株式会社 Packaged beverage
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions

Also Published As

Publication number Publication date
WO2015126265A1 (en) 2015-08-27
PH12016501647A1 (en) 2017-02-06

Similar Documents

Publication Publication Date Title
EP3574078A4 (en) Stable unit dose compositions with high water content
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
CA2956871C (en) Compounds active towards bromodomains
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
MY189913A (en) Preparation containing tetracyclic compound at high dose
MX2017007839A (en) Low water dentifrice compositions.
TN2015000313A1 (en) Chemical compounds
MX2017002610A (en) INHIBITORS OF A-AMINO-ß-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE.
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
MX371128B (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof.
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2016015017A (en) Dentifrice compositions with improved fluoride stability.
EP3153156A4 (en) Composition based on a stabilized solution of active ingredients
EP3162811A4 (en) Peptide as absorption enhancer and composition containing same
PH12016501647B1 (en) Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency
EP3235808A4 (en) Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same
MX2016011572A (en) Organic acid antimicrobial compositions.
EP3195851A4 (en) Composition containing meso-2,3-butanediol
SG10201810093PA (en) Pharmaceutical composition for external use
EP3156040A4 (en) Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof
NZ750581A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
TH1601004693A (en) Oral liquid vitamin supplement containing stable zinc and vitamin C with reduced astringency.
GB2546703A (en) Compounds
MX2017001512A (en) Compounds active towards bromodomains.